Evaluation of four chemotherapy regimens for treatment of advanced AIDS-associated Kaposi sarcoma in Kenya: a cost-effectiveness analysis.
Saved in:
| Title: | Evaluation of four chemotherapy regimens for treatment of advanced AIDS-associated Kaposi sarcoma in Kenya: a cost-effectiveness analysis. |
|---|---|
| Authors: | Freeman EE; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Harvard University, Boston, MA, USA. Electronic address: efreeman@mgh.harvard.edu., McCann NC; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA., Semeere A; Infectious Diseases Institute, Kampala, Uganda; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA., Reddy KP; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA; Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Harvard University, Boston, MA, USA., Laker-Oketta M; Infectious Diseases Institute, Kampala, Uganda., Byakwaga H; Infectious Diseases Institute, Kampala, Uganda., Pei PP; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA., Hajny Fernandez ME; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA., Kiprono S; Department of Internal Medicine, Moi University School of Medicine, Eldoret, Kenya., Busakhala N; Department of Internal Medicine, Moi University School of Medicine, Eldoret, Kenya; Department of Pharmacology and Toxicology, Moi University School of Medicine, Eldoret, Kenya., Martin JN; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA., Maurer T; Department of Dermatology, Indiana University School of Medicine, Indianapolis, IN, USA., Bassett IV; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA; Division of Infectious Disease, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Harvard University, Boston, MA, USA., Freedberg KA; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA; Division of Infectious Disease, Massachusetts General Hospital, Boston, MA, USA; Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Harvard University, Boston, MA, USA., Hyle EP; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA; Division of Infectious Disease, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Harvard University, Boston, MA, USA. |
| Source: | The Lancet. Global health [Lancet Glob Health] 2022 Aug; Vol. 10 (8), pp. e1179-e1188. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101613665 Publication Model: Print Cited Medium: Internet ISSN: 2214-109X (Electronic) Linking ISSN: 2214109X NLM ISO Abbreviation: Lancet Glob Health Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
